Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

New treatment targets identified in opiate abstinence

Nov. 3, 2021

RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder

Nov. 2, 2021

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Oct. 8, 2021

New 5-HT2 receptor agonists identified

Oct. 6, 2021

NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties

Sep. 20, 2021

MC-100093 attenuates cocaine relapse in rats

Sep. 16, 2021

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Sep. 8, 2021

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Aug. 26, 2021

FDA clears IND application for DCR-AUD

July 30, 2021

Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose

July 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...